Delivery Order SPE2DE24DA017-SPE2D626F82S0

Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $2,423.52 on January 6, 2026, for the ACP MAX PRP System with ACDA (autologous conditioned plasma maximum platelet-rich plasma system) under a fixed-price contract with economic price adjustment provisions. The contract, which has an ultimate completion date of January 9, 2026, was issued without set-aside designation and reflects Arthrex's established competitive position as a leading supplier of minimally invasive orthopedic medical technologies to federal healthcare systems. This delivery order falls under Arthrex's larger single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 billion and effective through September 1, 2029, which authorizes procurement of a comprehensive spectrum of orthopedic products and surgical technologies across Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide.

The work will be performed in Naples, Florida, with Arthrex serving as the prime contractor with no identified subcontractors. As a for-profit Subchapter S Corporation and primary supplier to DoD and VA healthcare systems, Arthrex has demonstrated substantial federal contracting capability in delivering advanced orthopedic solutions including joint replacement systems, arthroscopic instruments, surgical implants, and biologics. The Medical Supply Chain, a division within the Defense Logistics Agency, funds this procurement to support comprehensive orthopedic healthcare requirements for military personnel and veterans across multiple surgical specialties. Arthrex's established track record includes numerous delivery orders and purchase orders, with recent contract activity exceeding $550,000 across multiple Veterans Integrated Service Networks.